Ontology highlight
ABSTRACT:
INSTRUMENT(S): Orbitrap Fusion
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): B Cell, Blood
DISEASE(S): Acute Leukemia
SUBMITTER: Vishwajeeth Pagala
LAB HEAD: Tanja A. Gruber
PROVIDER: PXD038845 | Pride | 2023-02-15
REPOSITORIES: Pride
Nature communications 20230213 1
Rearrangments in Histone-lysine-N-methyltransferase 2A (KMT2Ar) are associated with pediatric, adult and therapy-induced acute leukemias. Infants with KMT2Ar acute lymphoblastic leukemia (ALL) have a poor prognosis with an event-free-survival of 38%. Herein we evaluate 1116 FDA approved compounds in primary KMT2Ar infant ALL specimens and identify a sensitivity to proteasome inhibition. Upon exposure to this class of agents, cells demonstrate a depletion of histone H2B monoubiquitination (H2Bub1 ...[more]